Freshly Pardoned Crypto King Arthur Hayes Makes Bold Move Into Stem Cell Startup Investment

Just months after receiving a presidential pardon from Donald Trump, cryptocurrency pioneer Arthur Hayes is diving headfirst into biotechnology—because what better way to follow crypto volatility than betting on the future of human regeneration?

The Investment Thesis

Hayes, former CEO of BitMEX, is channeling his notorious risk appetite into stem cell research. The move signals a classic crypto-to-biotech pivot—where else do you go after revolutionizing finance? The startup remains unnamed, but sources confirm Hayes is leading the funding round personally.

Market Reactions

Traditional finance analysts are scratching their heads while crypto circles buzz with speculation. Hayes’ track record of disruptive innovation suggests this isn’t just another celebrity investment—it’s a calculated gamble on the next frontier of technological convergence.

Because nothing says 'stable investment' like combining Trump-pardoned crypto energy with experimental medical science—Wall Street bankers are probably still trying to explain NFTs to their clients.

Arthur Hayes is moving from crypto battles to stem cell clinics. The BitMEX co-founder, recently pardoned by U.S. President Donald Trump, has taken a board seat and a major stake in a stem cell company – the same firm where he’s been a patient for more than a year.

“I want to live as long as possible, as healthy as possible,” Hayes said, adding that more countries are beginning to ease rules around stem cell treatments. 

The company, currently rebranding, has not been named. Hayes has been traveling to clinics in Mexico and Bangkok for infusions aimed at extending his healthspan.

Crypto Titans Look Beyond Tokens

Hayes isn’t the only one. Some of crypto’s most familiar names are backing biotech and life-extension projects.

• Ethereum’s Vitalik Buterin donated millions, including $25 million in SHIB tokens, to aging research groups.
• Coinbase CEO Brian Armstrong co-founded NewLimit, a genetic startup that raised $130 million this year.
• Former Coinbase CTO Balaji Srinivasan co-founded Counsyl, a genomics company focused on disease screening.

For these crypto leaders, extending human life has become just as exciting as building the next blockchain.

Hayes Still Deep in Crypto

Even with his new focus, Hayes hasn’t stepped back from the industry that made him a billionaire. He still invests actively and often shares his market views and experiences with the crypto community, especially on X.

His family office,, funds Bitcoin developers with grants worth up to $250,000 each and has invested in digital asset treasury companies – public firms stockpiling crypto on their balance sheets.

The Trump Factor

Trump’s March pardon cleared Hayes and fellow BitMEX executives of their Bank Secrecy Act convictions. It marked a clean slate for Hayes, who built one of the world’s biggest derivatives exchanges before regulators cracked down.

Since then, TRUMP himself has embraced crypto, which Hayes sees as validation.

“If you have the president of the empire creating his own memecoin and it’s freely tradable, I think that gives license to other politicians to use memecoins as a way to do campaign finance,” he said.

Hayes also hinted that he’s preparing to release a detailed report on stablecoins, adding another LAYER to his ongoing influence in the crypto space.

Great chat with my fellow @Citi markets alum and absolute crypto OG @CryptoHayes. Always amazing to hear his perspective on macro and markets. Arthur teased a soon to be released report on stablecoins. Oh, we had a chance to get his perspective on DATs, too. Great pod. https://t.co/EViMcIIkjg